 |
Conway Strategic backstopped Perrigo’s PR team on the launch of Opill, the first ever over-the-counter birth control pill to receive the approval of the Food and Drug Administration.
Perrigo CEO Patrick Lockwood-Taylor said the FDA nod represented “a truly momentous day for women’s health nationwide.”
He said Opill “has the potential to radically transform women's access to contraception and is a true testament of Perrigo's unwavering commitment to deliver impactful solutions that truly make lives better.”
The New York Times reported on July 13 that more than 75 percent of women of reproductive age favor an OTC pill.
Nearly a third of women who have tried to get a prescription for a contraceptive pill reported difficulties in doing so. Forty five percent of the six million pregnancies in the US per year are unintended.
Perrigo expects Opill will be available at US retailers in 2024.
Conway Strategic, which describes itself as a woman and queer owned shop of moms and others committed to a work-life balance, is based in Washington.
Conway prinicipal Chrissy Faessen worked the media for the Opill launch.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
